BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9292537)

  • 21. Preconditioning with fetal cord blood facilitates engraftment of primary childhood T-cell acute lymphoblastic leukemia in immunodeficient mice.
    Dialynas DP; Lee MJ; Gold DP; Shao Le ; Yu AL; Borowitz MJ; Yu J
    Blood; 2001 May; 97(10):3218-25. PubMed ID: 11342452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful engraftment by leukemia initiating cells in adult acute lymphoblastic leukemia after direct intrahepatic injection into unconditioned newborn NOD/SCID mice.
    Cheung AM; Fung TK; Fan AK; Wan TS; Chow HC; Leung JC; Chan LY; Kwong YL; Liang R; Leung AY
    Exp Hematol; 2010 Jan; 38(1):3-10. PubMed ID: 19837128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth and biologic properties of karyotypically defined subcategories of adult acute lymphocytic leukemia in mice with severe combined immunodeficiency.
    Jeha S; Kantarjian H; O'Brien S; Huh Y; Pisa P; Ordonez N; Beran M
    Blood; 1995 Dec; 86(11):4278-85. PubMed ID: 7492788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.
    Agliano A; Martin-Padura I; Mancuso P; Marighetti P; Rabascio C; Pruneri G; Shultz LD; Bertolini F
    Int J Cancer; 2008 Nov; 123(9):2222-7. PubMed ID: 18688847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of engraftment in different strains of immunodeficient mice reconstituted with human peripheral blood lymphocytes.
    Berney T; Molano RD; Pileggi A; Cattan P; Li H; Ricordi C; Inverardi L
    Transplantation; 2001 Jul; 72(1):133-40. PubMed ID: 11468548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engraftment of acute myeloid leukemia in NOD/SCID mice is independent of CXCR4 and predicts poor patient survival.
    Monaco G; Konopleva M; Munsell M; Leysath C; Wang RY; Jackson CE; Korbling M; Estey E; Belmont J; Andreeff M
    Stem Cells; 2004; 22(2):188-201. PubMed ID: 14990858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/gammac(null) mice: suppression by an inhibitor against NF-kappaB.
    Dewan MZ; Terashima K; Taruishi M; Hasegawa H; Ito M; Tanaka Y; Mori N; Sata T; Koyanagi Y; Maeda M; Kubuki Y; Okayama A; Fujii M; Yamamoto N
    J Virol; 2003 May; 77(9):5286-94. PubMed ID: 12692230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring of engraftment and progression of acute lymphoblastic leukemia in individual NOD/SCID mice.
    Nijmeijer BA; Mollevanger P; van Zelderen-Bhola SL; Kluin-Nelemans HC; Willemze R; Falkenburg JH
    Exp Hematol; 2001 Mar; 29(3):322-9. PubMed ID: 11274760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo anti-leukemic efficacy of anti-CD7-pokeweed antiviral protein immunotoxin against human T-lineage acute lymphoblastic leukemia/lymphoma in mice with severe combined immunodeficiency.
    Gunther R; Chelstrom LM; Finnegan D; Tuel-Ahlgren L; Irvin JD; Myers DE; Uckun FM
    Leukemia; 1993 Feb; 7(2):298-309. PubMed ID: 7678882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.
    Ito M; Hiramatsu H; Kobayashi K; Suzue K; Kawahata M; Hioki K; Ueyama Y; Koyanagi Y; Sugamura K; Tsuji K; Heike T; Nakahata T
    Blood; 2002 Nov; 100(9):3175-82. PubMed ID: 12384415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The kinetics and extent of engraftment of chronic myelogenous leukemia cells in non-obese diabetic/severe combined immunodeficiency mice reflect the phase of the donor's disease: an in vivo model of chronic myelogenous leukemia biology.
    Dazzi F; Capelli D; Hasserjian R; Cotter F; Corbo M; Poletti A; Chinswangwatanakul W; Goldman JM; Gordon MY
    Blood; 1998 Aug; 92(4):1390-6. PubMed ID: 9694728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice.
    Greiner DL; Shultz LD; Yates J; Appel MC; Perdrizet G; Hesselton RM; Schweitzer I; Beamer WG; Shultz KL; Pelsue SC
    Am J Pathol; 1995 Apr; 146(4):888-902. PubMed ID: 7717456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autonomous growth potential of leukemia blast cells is associated with poor prognosis in human acute leukemias.
    Yan Y; Wieman EA; Guan X; Jakubowski AA; Steinherz PG; O'Reilly RJ
    J Hematol Oncol; 2009 Dec; 2():51. PubMed ID: 20040095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Establishment of Human Acute B-Lymphoblastic Leukemia--NOD/SCID Xenotransplant Mouse Model].
    Zhang X; Deng Y; Chen FL; Fang YJ; Zhang W; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):623-6. PubMed ID: 26117005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient mice.
    Paczulla AM; Dirnhofer S; Konantz M; Medinger M; Salih HR; Rothfelder K; Tsakiris DA; Passweg JR; Lundberg P; Lengerke C
    Haematologica; 2017 May; 102(5):854-864. PubMed ID: 28183848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel nonobese diabetic/severe combined immunodeficient xenograft model for chronic lymphocytic leukemia reflects important clinical characteristics of the disease.
    Dürig J; Ebeling P; Grabellus F; Sorg UR; Möllmann M; Schütt P; Göthert J; Sellmann L; Seeber S; Flasshove M; Dührsen U; Moritz T
    Cancer Res; 2007 Sep; 67(18):8653-61. PubMed ID: 17875705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IMC-EB10, an anti-FLT3 monoclonal antibody, prolongs survival and reduces nonobese diabetic/severe combined immunodeficient engraftment of some acute lymphoblastic leukemia cell lines and primary leukemic samples.
    Piloto O; Nguyen B; Huso D; Kim KT; Li Y; Witte L; Hicklin DJ; Brown P; Small D
    Cancer Res; 2006 May; 66(9):4843-51. PubMed ID: 16651440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mouse as a model system to study the engraftment and mobilization of human peripheral blood stem cells.
    van der Loo JC; Hanenberg H; Cooper RJ; Luo FY; Lazaridis EN; Williams DA
    Blood; 1998 Oct; 92(7):2556-70. PubMed ID: 9746798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lineage switch in childhood leukemia with monosomy 7 and reverse of lineage switch in severe combined immunodeficient mice.
    Fujisaki H; Hara J; Takai K; Nakanishi K; Matsuda Y; Ohta H; Osugi Y; Tokimasa S; Taniike M; Hosoi G; Sako M; Okada S
    Exp Hematol; 1999 May; 27(5):826-33. PubMed ID: 10340398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice.
    Christianson SW; Greiner DL; Schweitzer IB; Gott B; Beamer GL; Schweitzer PA; Hesselton RM; Shultz LD
    Cell Immunol; 1996 Aug; 171(2):186-99. PubMed ID: 8806787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.